20 May 2013
Keywords: negative, news, merck, co, vioxx, cases, latest
Article | 28 August 2006
In the latest round of litigation alleging damages due to Merck & Co's COX-2 inhibitor Vioxx (rofecoxib), which was withdrawn in 2004, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.